About Fidabio

We assist you realizing the full potential of your complex biology beyond current technologies

Our Fidabio instruments are aimed at assisting you advancing your complex biology projects, like multiple-binding proteins, liposomes, exosomes and bispecifics. Our FIDA technology represents a new paradigm in in-solution, biophysical and biochemical characterization of proteins and nanoparticles. Measuring under native conditions directly in plasma, serum, cell lysate, fermentation broth etc. it enables new insights and more accurate analyses compared to other technologies. The result is more precise data and faster decision making.



Fidabio is founded by researchers at the University of Copenhagen, who are the inventors of the FIDA technology.


Board of directors

Ole Kring, Partner, Vækstfonden Venture

Ole Vorm, CEO and Founder, Evosep ApS

Jay Teich, Teich Technology Investments LLC

Jørgen Schøller, Head of Department of Health Technology, Technical University of Denmark